Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease
Clinical trial NCT03664804 · COMPLETED
Trial details
- NCT number
- NCT03664804
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-05
- Primary completion
- 2021-05-07
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.